ADIPOQ and metabolic dysfunction-associated steatotic liver disease: The adiponectin rs266729 polymorphism increased the risk of NAFLD in codominant and dominant tested inheritance models (OR = 2.18, 95% CI = 1.16 – 4.12, P = 0.016, CC vs CG; and OR = 2.31, 95% CI = 1.25 - 4.27, P = 0.008, CC vs CG - GG, respectively).